SuYvonne Bell, manager of sales operations, North American Fleet, Gilead Sciences. -

SuYvonne Bell, manager of sales operations, North American Fleet, Gilead Sciences.

Gilead Sciences has promoted its former senior fleet analyst, SuYvonne Bell, to a new position as the manager of sales operations for its North American Fleet. In her expanded role, she will have a direct impact on pioneering initiatives for the fleet program. 

Bell previously served as the senior analyst for Gilead’s North American commercial fleet operations where she was responsible for the development, implementation, coordination, and oversight of fleet management policies and initiatives for the North America fleet program. This includes responsibility for specifications, policy, oversight, cost control, risk mitigation, and compliance.

She held her previous role with Gilead from August 2017 until her promotion in January 2020, during which time she was recognized as one of Automotive Fleet’s Fleet Visionary Honorees at the 2019 Automotive Fleet & Leasing Association (AFLA) Conference. Bell was also awarded Gilead’s Commercial Operations Vision Award in 2017. Under her management, Wheels, Inc. honored Gilead with the 2019 Driver Productivity and Satisfaction Award.

Prior to her time with Gilead, she served at the national fleet analyst for Depomed, Inc., where her duties included researching and aligning optimal and analytical services for its fleet program for field-based sales, vehicle replacement schedule, performance benchmarking, action plan tracking, training and vendor management.

While at Depomed, she developed and implemented fleet service initiatives including employer driver handbook, fleet calendar of events, bi-annual fleet vehicle inspections to increase driver customer satisfaction, and communication of fleet services, among other tasks. Before this, she served as the company’s commercial operations analyst.

Earlier, she held various positions for companies like BioMarin Pharmaceutical Inc. and Mylan Pharmaceuticals.

0 Comments